PMA supplement
BP120001 S335: OraQuick? In-Home HIV Test
FDA PMA supplement · 30-Day Notice · OraSure Technologies, Inc
Key facts
| Original PMA | BP120001 |
|---|---|
| Supplement number | S335 |
| Supplement type | 30-Day Notice |
| Trade name | OraQuick? In-Home HIV Test |
| Generic name | Hiv self-tests |
| Applicant | OraSure Technologies, Inc |
| Product code | QSS |
| Received date | Apr 14, 2017 |
| Decision date | May 12, 2017 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: